Transient disappearance of CD19+/CD5+ B‐lymphocyte clone in peripheral blood in a patient with CLL during SARS‐CoV‐2‐related mild disease. Issue 6 (22nd June 2021)

• Record Type: Journal Article
• Authors: Barnabei, Remo; Di Michele, Giulio; Cellini, Antonio; Amicosante, Gianfranco; Perilli, Mariagrazia; Bellio, Pierangelo; Piccirilli, Alessandra; Celenza, Giuseppe
• Is Part Of: Clinical case reports. Volume 9:Issue 6(2021)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-22
• Subjects: CD19+/CD5+ clone -- lymphocytic leukemia -- SARS‐CoV‐2; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.4238
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Although lymphopenia is currently considered a good predictor for the prognosis of COVID‐19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment. Abstract : Although lymphopenia is currently considered a good predictor for the prognosis of COVID‐19, it must be critically evaluated in patients with CLL, where other clinical markers should be considered to define the prognosis and treatment. ​